BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Prognosis
15 results:

  • 1. ER-positive and BRCA2-mutated breast cancer: a literature review.
    Li PC; Zhu YF; Cao WM; Li B
    Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term survival outcomes of salvage [
    Ballal S; Yadav MP; Satapathy S; Raju S; Tripathi M; Damle NA; Sahoo RK; Bal C
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3777-3789. PubMed ID: 37462775
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LncRNA UBE2R2-AS1, as prognostic marker, promotes cell proliferation and EMT in prostate cancer.
    Wang F; Zhao M; Jiang Y; Xia S; Sun D; Zhou D; Dong Z
    Histol Histopathol; 2023 Jun; 38(6):637-645. PubMed ID: 35916204
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cytotoxic Marine Alkaloid 3,10-Dibromofascaplysin Induces Apoptosis and Synergizes with Cytarabine Resulting in Leukemia Cell Death.
    Spirin P; Shyrokova E; Lebedev T; Vagapova E; Smirnova P; Kantemirov A; Dyshlovoy SA; Amsberg GV; Zhidkov M; Prassolov V
    Mar Drugs; 2021 Aug; 19(9):. PubMed ID: 34564151
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. AS1 expression in prostate cancer and its effects on proliferation and invasion of prostate cancer cells.
    Li Y; Zhuang X; Zhuang L; Liu H
    Cancer Biomark; 2021; 32(3):271-279. PubMed ID: 34151833
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LncRNA ADAMTS9-AS1 knockdown restricts cell proliferation and EMT in non-small cell lung cancer.
    Li Z; Yue G; Zhang T; Wu J; Tian X
    Histol Histopathol; 2021 Oct; 36(10):1063-1072. PubMed ID: 34085704
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Stromal osseous metaplasia in urothelial carcinoma of the bladder: a rare case report and literature review.
    Razafimahefa J; Gosset C; Mongiat-Artus P; Andriamampionona TF; Verine J
    Diagn Pathol; 2019 Jul; 14(1):75. PubMed ID: 31299983
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Glycidamide Promotes the Growth and Migratory Ability of prostate cancer Cells by Changing the Protein Expression of Cell Cycle Regulators and Epithelial-to-Mesenchymal Transition (EMT)-Associated Proteins with Prognostic Relevance.
    Ekanem TI; Huang CC; Wu MH; Lin DY; Lai WT; Lee KH
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060254
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
    Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
    Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503.
    Qi H; Wen B; Wu Q; Cheng W; Lou J; Wei J; Huang J; Yao X; Weng G
    Biomed Pharmacother; 2018 Jun; 102():326-332. PubMed ID: 29571017
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Formulation and in vitro efficacy of liposomes containing the Hsp90 inhibitor 6BrCaQ in prostate cancer cells.
    Sauvage F; Franzè S; Bruneau A; Alami M; Denis S; Nicolas V; Lesieur S; Legrand FX; Barratt G; Messaoudi S; Vergnaud-Gauduchon J
    Int J Pharm; 2016 Feb; 499(1-2):101-109. PubMed ID: 26721724
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fifteen-year mortality after radical prostatectomy: which factors are available for patient counselling?
    Wæhre H; Vlatkovic L; Cvancarova M; Paus E; Fosså SD; Danielsen HE
    Scand J Urol; 2014 Apr; 48(2):123-30. PubMed ID: 23885810
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of serum on (-)-gossypol-suppressed growth in human prostate cancer cells.
    Huang YW; Wang LS; Chang HL; Ye W; Sugimoto Y; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2006; 26(5A):3613-20. PubMed ID: 17094491
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Gains of the relative genomic content of erbB-1 and erbB-2 in prostate carcinoma and their association with metastasis.
    Schwartz S; Caceres C; Morote J; De Torres I; Rodriguez-Vallejo JM; Gonzalez J; Reventos J
    Int J Oncol; 1999 Feb; 14(2):367-71. PubMed ID: 9917515
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.